Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Burning Rock Biotech (BNR) EPS (Basic): 2020-2025

Historic EPS (Basic) for Burning Rock Biotech (BNR) over the last 6 years, with Sep 2025 value amounting to $0.16.

  • Burning Rock Biotech's EPS (Basic) fell 91.61% to $0.16 in Q3 2025 from the same period last year, while for Sep 2025 it was -$0.23, marking a year-over-year decrease of 106.68%. This contributed to the annual value of -$0.44 for FY2024, which is 50.24% up from last year.
  • As of Q3 2025, Burning Rock Biotech's EPS (Basic) stood at $0.16, which was up 182.25% from -$0.19 recorded in Q2 2025.
  • In the past 5 years, Burning Rock Biotech's EPS (Basic) registered a high of $5.91 during Q4 2022, and its lowest value of -$2.19 during Q3 2022.
  • Over the past 3 years, Burning Rock Biotech's median EPS (Basic) value was -$0.19 (recorded in 2025), while the average stood at $0.00.
  • Data for Burning Rock Biotech's EPS (Basic) shows a peak YoY increase of 1,614.48% (in 2022) and a maximum YoY decrease of 767.76% (in 2022) over the last 5 years.
  • Burning Rock Biotech's EPS (Basic) (Quarterly) stood at -$0.39 in 2021, then soared by 1,614.48% to $5.91 in 2022, then crashed by 34.33% to $3.88 in 2023, then tumbled by 102.05% to -$0.08 in 2024, then plummeted by 91.61% to $0.16 in 2025.
  • Its EPS (Basic) was $0.16 in Q3 2025, compared to -$0.19 in Q2 2025 and -$0.12 in Q1 2025.